New Equipment Launched at the Hematology Center Laboratory of Lanzhou Heavy Ion Hospital, Enabling Precision Diagnosis of Hematological Diseases for Clinical Departments

New Equipment Launched at the Hematology Center Laboratory

Enabling Precision Diagnosis of Hematological Diseases for Clinical Departments

On August 25, 2025, the newly purchased bone marrow cell morphology analysis system platform was officially launched at the Hematology Center Laboratory of Lanzhou Heavy Ion Hospital. This platform is equipped with advanced facilities such as the OLMPUS BX43 biological microscope, LABB high-definition camera, digital cell counting system, and color printing system. On the same day, the Hematology Center Laboratory was able to perform bone marrow cell morphology analysis and peripheral blood cell morphology analysis, quickly and efficiently providing clinical departments with high-quality, illustrated bone marrow cell morphology reports and peripheral blood cell morphology reports. This assists various clinical departments within the hospital and neighboring sister hospitals in analyzing and diagnosing abnormal blood cell counts in outpatient and inpatient cases, analyzing bone marrow suppression after diseases and radiotherapy/chemotherapy, hematological diseases, lymphatic system diseases, bone marrow metastatic cancer, fever of unknown origin, special infectious diseases, hematological parasitic diseases, and more. In the future, the laboratory will be able to conduct high-precision medical testing experiments such as flow cytometry. It will also provide disease scientific research data for related specialized departments such as hematology, oncology, and radiotherapy/chemotherapy.

Hematology Center Laboratory

Pan Ming

Director of Hematology Oncology Department, Director of Hematology Center Laboratory, Chief Expert in Hematology

First-Class Chief Physician

Started working in July 1984. In 2001, completed a one-year advanced training program in the Hematology Department and Hematology Research Institute of the China-Japan Friendship Hospital (under the Ministry of Health), where Professor Wang Fengji (first to fourth-term head of the Morphology Group of the Chinese Society of Hematology) was located. Studied bone marrow hematocyte morphology (experimental hematology) under Teacher Wang Yinping. In 2002, established Wuwei City's first hematology specialty—the Hematology Department of Wuwei People's Hospital (a provincial-level key discipline), the Hematology Center Laboratory (a municipal-level key laboratory), and the Wuwei Hematology Research and Treatment Center (under the Municipal Science and Technology Bureau). After 2003, participated in short-term advanced training programs at the Hematology Department of Ruijin Hospital (Shanghai Jiao Tong University), the Hematology Department of the First Affiliated Hospital of Soochow University, the Hematology Department of the First Affiliated Hospital of Xuzhou Medical University, the Hematology Department of Sun Yat-sen University Cancer Hospital, the Tianjin Hematology Hospital of the Chinese Academy of Medical Sciences, and the Hematology Department of Peking Union Medical College. In 2017, participated in the Gansu Provincial Leading Talent Clinical Research and Innovation Capacity Training Program at Skåne University Hospital and Lund University Hospital (Lund University and Region Skåne Hospital Care). Published over 50 papers as first author in academic journals such as SCI and CSCD. Co-authored five books, including "Annals of Wuwei Regional People's Hospital" and "Internal Medicine Diagnosis Order Manual." Completed 11 Gansu Provincial Natural Science Foundation projects and provincial/municipal research projects as first principal investigator, and received 10 provincial/municipal awards for scientific and technological progress and medical science and technology awards. Currently serves as: First-term Committee Member of the Hematology Institutions Branch of the Chinese Hospital Association; Standing Committee Member of the Hemophilia Group of the China Rare Disease Alliance; Committee Member of the Transplantation and Plasmapheresis Group of the Stem Cell Engineering Technology Branch of the Chinese Society of Biomedical Engineering; Committee Member of the Hemostasis and Thrombosis Branch of the China Medicine Education Association; Committee Member of the Hematology Branch of the Chinese Society of Traditional Chinese Medicine; Council Member of the Hematology Branch of the Chinese Ethnic Medicine Association; Vice Chairman of the Hematology Physician Branch of the Gansu Provincial Medical Doctor Association; Second-term Vice Chairman of the Lymphoma Professional Committee of the Gansu Provincial Anti-Cancer Association; Vice Chairman of the First-term Gansu Provincial Alliance Lymphoma Professional Committee of the China Cancer Prevention and Control Alliance; Standing Committee Member of the Seventh and Eighth Gansu Provincial Medical Association Hematology Society; Standing Committee Member of the Hematology Society of the Gansu Provincial Integrated Traditional and Western Medicine Association; Standing Committee Member of the Hematology Professional Committee of the Integrated Medicine Physician Branch of the Gansu Provincial Medical Doctor Association; First-term Standing Committee Member of the Hematology Translational Medicine Professional Committee of the Gansu Provincial Anti-Cancer Association; Standing Committee Member of the Hematology Oncology Professional Committee of the Gansu Provincial Traditional Chinese Medicine Association; Council Member of the Gansu Provincial Integrated Traditional and Western Medicine Association; Council Member of the Gansu Provincial Anti-Cancer Association; Committee Member of the Integrated Medicine Physician Branch of the Gansu Provincial Medical Doctor Association; Vice President of the Wuwei Medical Association; First and Second-term Chairman of the Hematology Professional Committee of the Wuwei Medical Association. Recognized as: Leading Talent of the Gansu Provincial Health Department; Leader of the Provincial-Level Key Medical Discipline (Hematology) in Gansu Province; Academic and Technical Leader of Gansu Provincial Medical and Health System for Middle-Aged and Young Professionals; Famous Traditional Chinese Medicine Practitioner of Gansu Province; Outstanding Science and Technology Worker of Gansu Province; Outstanding Communist Party Member of the Gansu Provincial Health System; Leading Talent of Wuwei City; Top Ten Outstanding Young Intellectuals of Wuwei City; Outstanding Science and Technology Worker of Wuwei City. Awarded the Gansu Provincial "May 1st" Labor Medal and "Good Person of Gansu" honor. Receives the Gansu Provincial High-Level Professional Technical Talent allowance. Specializes in the diagnosis and treatment of various types of anemia, aplastic anemia, hemolytic diseases, acute and chronic leukemia, lymphoma, multiple myeloma, MDS, myeloproliferative tumors, bone marrow metastatic cancer, thrombocytopenia, thrombosis and bleeding, TTP, allergic purpura, DIC, and other hematological and lymphatic system diseases; bone marrow hematocyte morphology analysis research; hematopoietic stem cell transplantation; and integrated traditional Chinese and Western medicine diagnosis and treatment of internal medicine difficult diseases.

Wang Lei

Diagnostic Physician

Graduated from Xinjiang Medical University in 2024 with a master's degree. Started working in 2024. Completed residency training from 2021 to 2024. Recognized as an Outstanding Volunteer in Southern Xinjiang Pandemic Prevention and Control. Received the Outstanding Award in a Municipal Medical Science Popularization Speech Contest. Served as an official medical emergency runner for marathons. Participated in one National Natural Science Foundation project. Specializes in the full-course management of common solid tumors and the diagnosis and treatment of various anemias, bleeding and thrombotic diseases, and chronic leukemia. Proficient in the standardized diagnosis and treatment of hematological diseases (such as thrombocytopenia, acute and chronic leukemia, multiple myeloma, etc.) and the treatment of solid tumors (such as lung cancer, breast cancer, gastric cancer, etc.). Familiar with experimental procedures such as mononuclear cell extraction, flow cytometry, RT-PCR, and ELISA.

Address of the Hematology Center Laboratory

West Side, 2nd Floor, Outpatient-Inpatient Comprehensive Building, Lanzhou Heavy Ion Hospital

Contact: Dr. Wang Lei, 15569684537

Hematology Oncology Department Doctor's Office (11th Floor, Inpatient Building)

Contact: 0931-2169583

Oncology Department/Hematology Department

Professional Team

The department has an elite team of professional medical staff. Among the medical team, specially appointed experts Professor Bai Hai and Professor Pan Ming are both first-class chief physicians, enjoying high reputations in the industry with profound academic achievements and rich clinical experience, providing solid assurance for the department's diagnosis and treatment level. At the same time, the department is equipped with a reasonable and complete talent team, and continuously improves and enhances the talent training mechanism to ensure high-quality, multi-level medical services for patients. The nursing team, with a high sense of responsibility and professional nursing skills, provides comprehensive and refine nursing services to ensure patient comfort and safety during treatment.

Scope of Diagnosis and Treatment

The department focuses on the precise diagnosis and treatment of various benign and malignant hematological and solid tumor diseases. It has significant advantages in handling refractory and relapsed hematological diseases and solid tumor diseases. Key areas include hematological diseases such as leukemia, lymphoma, multiple myeloma, and various types of anemia, as well as common solid tumor diseases such as lung cancer, gastric cancer, colorectal cancer, breast cancer, etc., for internal medicine treatment. Whether for common diseases or difficult diseases, the department can provide accurate diagnosis and effective treatment plans based on professional medical technology and rich clinical experience.

Diagnosis and Treatment Technologies

Diversified Treatment Methods: The department adopts internationally advanced treatment concepts and methods, including chemotherapy, targeted therapy, immunotherapy, endocrine therapy, supportive therapy, cell therapy, and integrated traditional Chinese and Western medicine treatment. Based on the patient's condition and physical condition, personalized comprehensive treatment plans are developed to achieve the best treatment outcomes.

Precision Diagnostic Technologies: Relying on the advanced bone marrow morphology, bone marrow pathology, flow cytometry, genetic testing, and other MICM typing technologies of the Hematology Center Laboratory, the department can accurately diagnose and type hematological diseases, providing a scientific basis for developing personalized diagnosis and treatment plans. Through these advanced technologies, the patient's condition can be understood more accurately, enabling precise treatment and improving treatment efficacy.

Laminar Flow Ward Assurance: The department is equipped with laminar flow wards, providing a safe and comfortable treatment environment for patients requiring high-dose chemotherapy, hematopoietic stem cell transplantation, and other treatments with high infection control requirements. The laminar flow wards use advanced air purification technology to effectively reduce infection risks, providing strong assurance for patient treatment.

Preliminary Review: Ma Shuqian

Final Review: Liu Wenyu